- Satellos gives early look at Duchenne pill in adults ahead of key data in childrenSatellos Bioscience is building its case for a Duchenne muscular dystrophy pill with data in adult patients ahead of a potentially pivotal readout in children later this year. The Canadian biotec…Endpoints · 17d ago↗ source
- Vertex's Crinetics deal points to big ambitions for cystic fibrosis leaderVertex Pharmaceuticals' $10 billion acquisition of an endocrinology startup represents the company’s clearest and boldest step toward the upper echelon of the biopharma industry. Long a biotech s…Endpoints · 17d ago↗ source
- Tampa General kicks off legal fight over Lilly's 340B restrictionsTampa General Hospital sued Eli Lilly for halting its 340B discounts, kicking off a broader fight over whether pharmaceutical companies can condition drug discounts on new claims data requirements.…